(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.34%) $79.26
(5.62%) $2.31
(0.78%) $2 340.30
(2.77%) $28.37
(0.85%) $993.00
(-0.28%) $0.927
(-0.23%) $10.87
(-0.21%) $0.798
(0.88%) $92.54
5 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 0.00%
-1.09% $ 8.14
Live Chart Being Loaded With Signals
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform...
Stats | |
---|---|
Volumen de hoy | 226 369 |
Volumen promedio | 803 516 |
Capitalización de mercado | 251.33M |
EPS | $0 ( 2024-03-26 ) |
Próxima fecha de ganancias | ( $-0.890 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.97 |
ATR14 | $0.0540 (0.66%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Miller Mary | Sell | 558 | Common Stock |
2024-04-11 | Ra Capital Management, L.p. | Buy | 3 530 000 | Common Stock |
2024-04-11 | Perceptive Advisors Llc | Buy | 2 353 000 | Common Stock |
2024-03-04 | Palani Santhosh | Buy | 32 500 | Stock Option (Right to Buy) |
2024-03-04 | Palani Santhosh | Buy | 0 |
INSIDER POWER |
---|
24.75 |
Last 56 transactions |
Buy: 13 025 326 | Sell: 16 556 327 |
Volumen Correlación
Acrivon Therapeutics, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acrivon Therapeutics, Correlación - Moneda/Commodity
Acrivon Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-536 000 (0.00 %) |
EPS: | $-2.74 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-536 000 (0.00 %) |
EPS: | $-2.74 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.10M (0.00 %) |
EPS: | $-1.350 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.260 |
Financial Reports:
No articles found.
Acrivon Therapeutics,
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico